SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...
SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma Inc. reported in the October issue of “Cancer Chemotherapy and Pharmacology”*, a leading cancer journal, the final results of a Phase 1b cancer study ...
Randomized double-blind phase II trial comparing gemcitabine (GEM) plus LY293111 vs. GEM plus placebo in advanced adenocarcinoma of the pancreas ...
Curcumin may help lower the levels of molecules that cause inflammation, such as cytokines and enzymes. This may help with arthritis, asthma, and inflammatory bowel disease. Curcumin may improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results